CA2237571C - Combinaison de glibenclamide et de metformine destinee au traitement du diabete sucre de type ii - Google Patents

Combinaison de glibenclamide et de metformine destinee au traitement du diabete sucre de type ii Download PDF

Info

Publication number
CA2237571C
CA2237571C CA002237571A CA2237571A CA2237571C CA 2237571 C CA2237571 C CA 2237571C CA 002237571 A CA002237571 A CA 002237571A CA 2237571 A CA2237571 A CA 2237571A CA 2237571 C CA2237571 C CA 2237571C
Authority
CA
Canada
Prior art keywords
glibenclamide
metformin
combination
medicament
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CA002237571A
Other languages
English (en)
Other versions
CA2237571A1 (fr
Inventor
Giulio Barelli
Massimo De Regis
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Abiogen Pharma SRL
Original Assignee
Abiogen Pharma SRL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from IT95MI002337A external-priority patent/IT1276130B1/it
Application filed by Abiogen Pharma SRL filed Critical Abiogen Pharma SRL
Publication of CA2237571A1 publication Critical patent/CA2237571A1/fr
Application granted granted Critical
Publication of CA2237571C publication Critical patent/CA2237571C/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/64—Sulfonylureas, e.g. glibenclamide, tolbutamide, chlorpropamide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Cette combinaison de glibenclamide et de metformine est telle que, lors de son administration sous la forme d'une composition pharmaceutique dans le traitement du diabète sucré de type II, le rapport entre les deux principes actifs permet d'obtenir un effet thérapeutique optimum à n'importe quel moment de la progression de la maladie, et d'éviter ainsi le recours à la thérapie insulinique dans les cas les plus graves.
CA002237571A 1995-11-14 1996-11-07 Combinaison de glibenclamide et de metformine destinee au traitement du diabete sucre de type ii Expired - Fee Related CA2237571C (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
ITMI95A002337 1995-11-14
IT95MI002337A IT1276130B1 (it) 1995-11-14 1995-11-14 Associazione glibenclamide-metformina, composizioni farmaceutiche che la contengono e loro uso nel trattamento del diabete mellito di tipo
PCT/EP1996/004860 WO1997017975A1 (fr) 1995-11-14 1996-11-07 Combinaison de glibenclamide et de metformine destinee au traitement du diabete sucre de type ii

Publications (2)

Publication Number Publication Date
CA2237571A1 CA2237571A1 (fr) 1997-05-22
CA2237571C true CA2237571C (fr) 2007-01-23

Family

ID=37684470

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002237571A Expired - Fee Related CA2237571C (fr) 1995-11-14 1996-11-07 Combinaison de glibenclamide et de metformine destinee au traitement du diabete sucre de type ii

Country Status (1)

Country Link
CA (1) CA2237571C (fr)

Also Published As

Publication number Publication date
CA2237571A1 (fr) 1997-05-22

Similar Documents

Publication Publication Date Title
USRE37330E1 (en) Glibenclamide-metformin combination for the treatment of diabetes mellitus of type II
RU2276604C2 (ru) Антидиабетический препарат и способ лечения диабета
CA2389928C (fr) Procede utilise pour traiter le diabete
JP2003519621A5 (fr)
CA2237571C (fr) Combinaison de glibenclamide et de metformine destinee au traitement du diabete sucre de type ii
US8415360B2 (en) Pharmaceutical compositions for the treatment of diabetes mellitus
AU8022900B2 (fr)

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed

Effective date: 20161107